Physician profile
John E Cook
NPI 1093736779
$4,938.33
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,531 · 2020: $1,411 · 2021: $982 · 2022: $14.10.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,116.14 | 2019-2021 | |
| Flowonix Medical Incorporated | $649.85 | 2019-2020 | |
| Boston Scientific Corporation | $334.26 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $323.75 | 2019-2021 | |
| Amgen INC. | $276.73 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $196.95 | 2019-2021 | |
| Lilly USA, LLC | $175.39 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $162.76 | 2019-2020 | |
| Pfizer INC. | $162.02 | 2019-2020 | |
| Medtronic USA, INC. | $156.42 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $152.15 | 2019-2022 | |
| Biodelivery Sciences International, INC. | $124.80 | 2019 | |
| Biohaven Pharmaceuticals, INC. | $105.82 | 2020-2021 | |
| Pacira Therapeutics, INC. | $95.11 | 2019 | |
| Tersera Therapeutics LLC | $93.34 | 2019 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $87.89 | 2020-2021 | |
| Abbvie INC. | $70.80 | 2021 | |
| Almatica Pharma LLC | $70.10 | 2021 | |
| Bioventus LLC | $65.27 | 2019-2021 | |
| Lundbeck LLC | $55.84 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $55.63 | 2019-2020 | |
| Grt US Holding, INC. | $51.27 | 2020-2021 | |
| Virtus Pharmaceuticals LLC | $49.57 | 2021 | |
| Daiichi Sankyo INC. | $46.52 | 2019 | |
| Spr Therapeutics, INC | $41.67 | 2020 | |
| Si-Bone, INC. | $39.15 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $38.24 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $33.43 | 2019 | |
| Redhill Biopharma INC. | $30.97 | 2020 | |
| Upsher-Smith Laboratories LLC | $21.76 | 2019 | |
| Indivior INC. | $15.18 | 2019 | |
| Nevro Corp. | $15.13 | 2020 | |
| Spinal Simplicity, LLC | $12.79 | 2020 | |
| Baudax Bio INC. | $11.63 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.